ArticleNeuropsychiatric disease and treatment2024

TV-46000, A Long-Acting Subcutaneous Antipsychotic Agent, Demonstrated Improved Patient-Centered Outcomes in Patients with Schizophrenia.

Leslie Citrome et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.